It may sound like science fiction, but biotech company, COUR Pharmaceuticals is pioneering the use of nanoparticles to reprogram the immune system as a means of treating autoimmune diseases and severe allergies.
It may sound like science fiction, but biotech company, COUR Pharmaceuticals is pioneering the use of nanoparticles to reprogram the immune system as a means of treating autoimmune diseases and severe allergies.